A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya

BACKGROUND: Artemether/lumefantrine (AL) has been adopted as the treatment of choice for uncomplicated malaria in Kenya and other countries in the region. Six-dose artemether/lumefantrine tablets are highly effective and safe for the treatment of infants and children weighing between five and 25 kg...

Descripción completa

Detalles Bibliográficos
Autores principales: Juma, Elizabeth A, Obonyo, Charles O, Akhwale, Willis S, Ogutu, Bernhards R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635380/
https://www.ncbi.nlm.nih.gov/pubmed/19102746
http://dx.doi.org/10.1186/1475-2875-7-262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635380/
https://www.ncbi.nlm.nih.gov/pubmed/19102746
http://dx.doi.org/10.1186/1475-2875-7-262

Ejemplares similares